fda warning letters glp-1 october 2025 news FDA warnings against compounded GLP-1s

Patients with certain genetic patterns may benefit from the GLP-Squared Protocol combining compounded semaglutide and tirzepatide at $249 monthly, delivering synergistic appetite suppression that single-agent therapy cannot match

FDA-approved vs compounded: what each Florida path dispenses This distinction is the single most important thing to understand before choosing

GLP-1 and exenatide all correct each of those defects stimulating insulin secretion in a glucose-dependent fashion, and specifically, increasing the first-phase insulin response

Bojanowska E, Nowak A

It became clear that we needed a better way to help patients both navigate the shortage and find supply other than simply calling pharmacies and pointing to the FDAs website